Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 322 publications
Quizartinib for Newly Diagnosed FLT3-ITD-Negative Acute Myeloid Leukemia: The Randomized, Double-Blind, Placebo-Controlled, Phase 2 QUIWI Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 13, 2025
Recent insights and clinical issues in acute myeloid leukemia in older adults
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: October 01, 2025
Preliminary assessment of drug repurposing against virus-associated primary effusion lymphoma.
Journal: Journal of microbiology & biology education
Published: September 25, 2025
Rational design of next-generation FLT3 inhibitors in acute myeloid leukemia: From laboratory to clinics.
Journal: European journal of medicinal chemistry
Published: August 19, 2025
Design, synthesis and biological screening of some diaryl acetamide derivatives as potential cytotoxic agents on HL-60(TB) cell line.
Journal: Bioorganic chemistry
Published: July 31, 2025
Updates on Therapy Options in Fit and Unfit Patients with Newly Diagnosed AML.
Journal: Current treatment options in oncology
Published: July 30, 2025
QuANTUM-First: Clinical Validation of the LeukoStrat Companion Diagnostic for the Selection of Patients With Acute Myeloid Leukemia Harboring FMS-Like Tyrosine Kinase 3-Internal Tandem Duplications for Treatment With Quizartinib.
Journal: Archives of pathology & laboratory medicine
Published: July 25, 2025
Mechanistic study on nonylphenol-induced liver fibrosis via Pink1/Parkin-mediated mitophagy and lipid droplet degradation in hepatic stellate cells.
Journal: Ecotoxicology and environmental safety
Published: July 03, 2025
Synergy Between second-generation FLT3 inhibitors and the ERK1/2 inhibitor Ulixertinib in FLT3-ITD-mutated acute myeloid leukemia (AML) cells.
Journal: Medical oncology (Northwood, London, England)
Published: June 03, 2025
Targeting FLT3 Mutations in Acute Myeloid Leukemia: The Role of Quizartinib in Precision Medicine.
Journal: Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology
Published: June 02, 2025
Screening for Antileukemia Agents in FMS-like Tyrosine Kinase 3 (FLT3)-Mutated Acute Myeloid Leukemia Cells.
Journal: ACS pharmacology & translational science
Published: April 29, 2025
Inhibition of PINK1 senses ROS signaling to facilitate neuroblastoma cell pyroptosis.
Journal: Autophagy
Published: March 31, 2025
Last Updated: 10/31/2025